Loading viewer...
investor_presentation
Format: PDF investor_presentation
UOB Group presents a transformational acquisition strategy to scale its Southeast Asian franchise across ASEAN markets. The deal is structured to be immediately accretive to EPS and ROE (excluding one-off costs), with ~40% income uplift and targets for >13% ROE by 2026. The acquisition maintains strong CET1 capital ratios above 13% and supports a 50% dividend payout ratio while strengthening regional capabilities.
investor_presentation
investor_presentation
13 Pages
RxSight
investor_presentation
Ocugen
investor_presentation
Wayfair
RadioPharm Theranostics CEO Presentation March 2022
investor_presentationinvestor_presentation
13 Pages
RadioPharm Theranostics Ltd